Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 886 AL 900

Frontier View on Nanotechnological Strategies for Neuro-therapy

Azhar A, Ashraf GM, Zia Q, Ansari SA, Perveen A, Hafeez A, Saeed M, Kamal MA, Alexiou A, Ganash M, Yarla NS, Baeesa SS, Alfiky MM, Bajouh OS.

Curr Drug Metab. 2018;19(7):596-604. doi: 10.2174/1389200219666180305144143.

Dysfunction in Brain-Derived Neurotrophic Factor Signaling Pathway and Susceptibility to Schizophrenia, Parkinson's and Alzheimer's Diseases

Mohammadi A, Amooeian VG, Rashidi E.

Curr Gene Ther. 2018;18(1):45-63. doi: 10.2174/1566523218666180302163029.

Functional Connectivity of the Corticobasal Ganglia-Thalamocortical Network in Parkinson Disease: A Systematic Review and Meta-Analysis with Cross-Validation

Ji GJ, Hu P, Liu TT, Li Y, Chen X, Zhu C, Tian Y, Chen X, Wang K.

Radiology. 2018 Jun;287(3):973-982. doi: 10.1148/radiol.2018172183. Epub 2018 Mar 7.

The Role of Insulin/IGF-1/PI3K/Akt/GSK3β Signaling in Parkinson's Disease Dementia

Yang L, Wang H, Liu L, Xie A.

Front Neurosci. 2018 Feb 20;12:73. doi: 10.3389/fnins.2018.00073. eCollection 2018.

Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease

Bridi JC, Hirth F.

Front Neurosci. 2018 Feb 19;12:80. doi: 10.3389/fnins.2018.00080. eCollection 2018.

Caregiver burden and its related factors in advanced Parkinson's disease: data from the PREDICT study

Tessitore A, Marano P, Modugno N, Pontieri FE, Tambasco N, Canesi M, Latorre A, Lopiano L, Sensi M, Quatrale R, Solla P, Defazio G, Melzi G, Costanzo AM, Gualberti G, di Luzio Paparatti U, Antonini A.

J Neurol. 2018 May;265(5):1124-1137. doi: 10.1007/s00415-018-8816-9. Epub 2018 Mar 7.

Molecular basis of dopamine replacement therapy and its side effects in Parkinson's disease

You H, Mariani LL, Mangone G, Le Febvre de Nailly D, Charbonnier-Beaupel F, Corvol JC.

Cell Tissue Res. 2018 Jul;373(1):111-135. doi: 10.1007/s00441-018-2813-2. Epub 2018 Mar 7.

Using tube feeding and levodopa-carbidopa intestinal gel application in advanced Parkinson's disease

Lex KM, Kundt FS, Lorenzl S.

Br J Nurs. 2018 Mar 8;27(5):259-262. doi: 10.12968/bjon.2018.27.5.259.

In vivo exploration of retinal nerve fiber layer morphology in Parkinson's disease patients

Visser F, Vermeer KA, Ghafaryasl B, Vlaar AMM, Apostolov V, van Hellenberg Hubar J, Weinstein HC, de Boer JF, Berendse HW.

J Neural Transm (Vienna). 2018 Jun;125(6):931-936. doi: 10.1007/s00702-018-1872-6. Epub 2018 Mar 8.

Pain in Parkinson's disease: facts and uncertainties

Antonini A, Tinazzi M, Abbruzzese G, Berardelli A, Chaudhuri KR, Defazio G, Ferreira J, Martinez-Martin P, Trenkwalder C, Rascol O.

Eur J Neurol. 2018 Jul;25(7):917-e69. doi: 10.1111/ene.13624. Epub 2018 Apr 18.

Presynaptic striatal dopaminergic depletion predicts the later development of freezing of gait in de novo Parkinson's disease: An analysis of the PPMI cohort

Kim R, Lee J, Kim Y, Kim A, Jang M, Kim HJ, Jeon B, Kang UJ, Fahn S.

Parkinsonism Relat Disord. 2018 Jun;51:49-54. doi: 10.1016/j.parkreldis.2018.02.047. Epub 2018 Feb 28.

Predictive Value of Parkinsonian Primates in Pharmacologic Studies: A Comparison between the Macaque, Marmoset, and Squirrel Monkey

Veyres N, Hamadjida A, Huot P.

J Pharmacol Exp Ther. 2018 May;365(2):379-397. doi: 10.1124/jpet.117.247171. Epub 2018 Mar 9.

Further evidence for a distinctive atypical degenerative parkinsonism in the Caribbean: A new cluster in the French West Indian Island of Martinique

Lannuzel A, Edragas R, Lackmy A, Tressières B, Pelonde V, Kaptué MEN, Mécharles S, Demas A, François B, McGovern E, Vidailhet M, Gaymard B, Roze E.

J Neurol Sci. 2018 May 15;388:214-219. doi: 10.1016/j.jns.2018.02.019. Epub 2018 Feb 6.

Mild Cognitive Impairment in Parkinson's Disease-What Is It?

Weil RS, Costantini AA, Schrag AE.

Curr Neurol Neurosci Rep. 2018 Mar 10;18(4):17. doi: 10.1007/s11910-018-0823-9.

Accounting for frailty when treating chronic diseases

Onder G, Vetrano DL, Marengoni A, Bell JS, Johnell K, Palmer K; Optimising Pharmacotherapy through Pharmacoepidemiology Network (OPPEN).

Eur J Intern Med. 2018 Oct;56:49-52. doi: 10.1016/j.ejim.2018.02.021. Epub 2018 Mar 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias